⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for International Lung Screen Trial (ILST)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: International Lung Screen Trial (ILST)

Official Title: International Lung Screen Trial

Study ID: NCT02871856

Interventions

Low dose CT

Study Description

Brief Summary: People who may be at increased risk of lung cancer due to age and smoking history will be invited to participate in this international study to determine the best way of using computed tomography (CT) of the chest to screen for early lung cancer. Overseas data show that CT screening (screening tests can find diseases early, when they're easier to treat) can reduce deaths from lung cancer and this study will help determine who is most likely benefit from screening.

Detailed Description: \[insert site name\]

Eligibility

Minimum Age: 55 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: Yes

Locations

St Vincent's Hospital, Sydney, New South Wales, Australia

The Prince Charles Hospital, Brisbane, Queensland, Australia

Royal Melbourne Hospital, Melbourne, Victoria, Australia

Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

Fiona Stanley Hospital, Perth, Western Australia, Australia

BC Cancer Research Centre, Vancouver, British Columbia, Canada

Contact Details

Name: Kwun M Fong

Affiliation: UQTRC at TPCH

Role: PRINCIPAL_INVESTIGATOR

Name: Steven Lam

Affiliation: British Columbia Cancer Agency

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: